— Know what they know.
Not Investment Advice
Also trades as: 0LO3.L (LSE) · $vol 0M · VEE.DE (XETRA) · $vol 0M

VEEV NYSE

Veeva Systems Inc.
1W: +1.3% 1M: -3.4% 3M: -12.2% YTD: -27.9% 1Y: -34.3% 3Y: -5.6% 5Y: -37.1%
$160.17
+1.90 (+1.20%)
 
Weekly Expected Move ±6.8%
$137 $148 $159 $170 $180
NYSE · Healthcare · Medical - Healthcare Information Services · Alpha Radar Strong Sell · Power 40 · $26.1B mcap · 150M float · 1.93% daily turnover · Short 59% of daily vol

Cash Flow Trends

Operating Cash Flow
$1.4B +29.8% ▲
5Y CAGR: +20.8%
Capital Expenditures
$29M -42.0% ▼
5Y CAGR: +27.4%
Free Cash Flow
$1.4B +29.6% ▲
5Y CAGR: +20.6%
Dividends Paid
$0 +0.0% ▲
Buybacks
$170M +0.0% ▲
Net Change in Cash
$302M -27.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$427M$488M$526M$714M$909M
Depreciation & Amort.$37M$38M$37M$51M$50M
Stock-Based Comp.$0$0$0$0$473M
Change in Working Capital$21M$7M$61M$8M-$92M
Other Non-Cash Items$268M$375M$393M$430M$10M
Operating Cash Flow$764M$780M$911M$1.1B$1.4B
— Investing Activities —
Capital Expenditures-$14M-$14M-$26M-$21M-$29M
Acquisitions (Net)-$8M$0$0$0$0
Investment Purchases-$1.1B-$2.0B-$2.7B-$2.6B-$3.1B
Investment Sales$793M$1.0B$1.6B$1.9B$2.1B
Other Investing$0$0$0$0$0
Investing Cash Flow-$346M-$1.0B-$1.1B-$700M-$1.1B
— Financing Activities —
Net Debt Issuance-$384K$0$0$0$0
Stock Repurchased$0$0$0$0-$170M
Dividends Paid$0$0$0$0$0
Other Financing-$55M-$63M-$79M-$79M-$93M
Financing Cash Flow-$4M-$19M-$16M$26M-$9M
Net Change in Cash$410M-$252M-$183M$414M$302M
Cash End of Period$1.1B$890M$707M$1.1B$1.4B
Free Cash Flow$750M$767M$885M$1.1B$1.4B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms